Recursion

📍 Salt Lake City, United States🗓 Founded 2013👥 713 employees💰 Last funded Nov 2025
Biotechnology Research🌐 recursion.com
Website LinkedIn
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
19
Total investors
2
Early stage
13
Mid stage
3
Late stage
2013
Founded

Investors

19 investors
All
Early stage
Mid stage
Late stage
Early stage· 2
Robert S.
Robert S.
Primary Care Healthcare Entrepreneur, Reinventing Primary Care, Bootstrapped the largest independent Primary Care system in Texas, 50+ Denovo Centers. Highest NPS in the USA with 35,000+ Reviews.
early stage
9 investments
Feb 2015
Nisa Leung 梁颕宇
Nisa Leung 梁颕宇
Managing Partner at Aulis Capital, Forbes Midas Lister
early stage
55 investments
2014
Mid stage· 13
BB
Blake Borgeson
MIRI + Recursion, AI + biology
Co-founder, Board Member
mid stage
Jul 2018
Alaa Halawa
Alaa Halawa
Investing in and building transformative companies at the intersection of technology and healthcare
Board Observer
mid stage
24 investments
Oct 2017
Hashem Taha
Hashem Taha
Building and investing in enterprise AI, bio, healthtech, & computational sciences.
mid stage
15 investments
Sep 2017
Dusan Perovic
Dusan Perovic
Founding Partner @ Deviation
mid stage
12 investments
Sep 2017
JH
James Hardiman
Partner at DCVC (Data Collective)
Investor and Board Observer
mid stage
10 investments
Jul 2017
David Beyer
David Beyer
Partner @ Amplify Partners. Co-founder @ Chartio.com (acq. Atlassian).
mid stage
24 investments
Feb 2017
Greg Yap
Greg Yap
Partner at Menlo Ventures
mid stage
23 investments
2017
Sundeep Peechu
Sundeep Peechu
Managing Partner at Felicis
mid stage
24 investments
Nov 2016
Nan Li
Nan Li
Founder @ Dimension
Investor, Board Observer
mid stage
16 investments
Oct 2016
Jack Boren
Jack Boren
Managing Partner at EPIC Ventures
mid stage
13 investments
Oct 2016
Vishal Vasishth
Vishal Vasishth
Co-Founder, Obvious Ventures ($1.5B AUM) | World Positive Investor-Philosopher-Operator | Henry Crown Fellow | Advisor to 50+ companies
mid stage
30 investments
Oct 2016
Zachary Bogue
Zachary Bogue
Cofounder and Managing Partner at DCVC
Investor & Board member
mid stage
19 investments
Aug 2016
Jason Godfrey
Jason Godfrey
Founder, President, CEO at Godfrey Capital
mid stage
26 investments
Aug 2016
Show all 19 investors ↓
Investor geography4 countries
United States
16
China
1
Canada
1
Singapore
1
Investor activity2014–2025 · investors recorded per year
2014120151201662017620181201922020120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Recursion?
Recursion has 19 investors on record on gritt.io, including 2 early-stage backers, 13 mid-stage and 3 late-stage investors.
When did Recursion last raise funding?
The most recent investment in Recursion recorded on gritt.io was in November 2025.
When was Recursion founded?
Recursion was founded in 2013.
What industry is Recursion in?
Recursion operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Recursion based?
Recursion is headquartered in Salt Lake City, United States.